Gibson Dunn Advised Arrowhead Pharmaceuticals on Asset Purchase Agreement with SanofiThe global law firm Gibson Dunn is advising Arrowhead Pharmaceuticals on an asset purchase agreement between Sanofi...
Gibson Dunn advised Arrowhead Pharmaceuticals on asset purchase agreement with Sanofi and Visirna TherapeuticsGlobal law firm Gibson Dunn is advising Arrowhead Pharmaceuticals on an asset purchase...
Freshfields Advised Sanofi On Its Acquisition Of Vigil Neuroscience Freshfields advised Sanofi S.A. on its pending acquisition of Vigil Neuroscience, Inc., a publicly traded clinical-stage...
Ropes & Gray Advised Sanofi In Acquisition Of Dren Bio’s Deep B-Cell Depleter Program The deal was worth to $1.9 billion American multinational law firm Ropes & Gray has advised Sanofi...
Goodwin Advised Dren Bio In Sanofi’s Acquisition Of Bispecific Myeloid Cell Engager The transaction is expected to close during Q2 2025. Goodwin’s life sciences team advised Dren Bio in a...
Unified Patent Court Repeals Amgen’s Cholesterol Drug Patent Against Sanofi And Regeneron This was the Pan-European court’s first revocation judgment after opening a year ago The Central division...
Radhika Shah joins SANOFI Radhika Shah joins SANOFI as a Company Secretary & Compliance Officer. Radhika has over 18 years of rich experience in Legal and Corporate Secretarial fields....
Panacea Biotech files suit in Delhi HC against Sanofi for patent infringement A suit has been filed by Panacea Biotech Limited before the Delhi High Court for restraining Sanofi Healthcare India Pvt....
